Stay updated with breaking news from Peter Dolinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This agreement enhances Multicare's oncology, rheumatology, gastroenterology, and ophthalmology, portfolio, which currently consists of three biosimilar candidates and over 50 generic medicines.
Uniindia: Mumbai, Sep 7 (UNI) Pharma major Lupin on Wednesday said it has signed an exclusive license and supply agreement to commercialize five of Alvotech’s proposed biosimilars in the Philippines with DKSH, a leading partner for healthcare companies<br /